Viral Encephalitis in the ICU

Critical Care Clinics

Volumn 29, Issue 3, 2013, Pages 621-649

  Kramer, Andreas H ^a  

^a FOOTHILLS HOSPITAL   (Canada)

Author keywords

Acute disseminated encephalomyelitis (ADEM); Anti NMDA receptor antibodies; Arbovirus; Coma; Encephalitis; Herpes simplex virus; Varicella zoster virus; West Nile virus

Indexed keywords

ACICLOVIR; ANTIPYRETIC AGENT; CYCLOPHOSPHAMIDE; DEXAMETHASONE; ETIRACETAM; FOSCARNET; FOSPHENYTOIN SODIUM; GANCICLOVIR; HARKOSERIDE; IMMUNOGLOBULIN; KETAMINE; LORAZEPAM; METHYLPREDNISOLONE; MIDAZOLAM; PHENYTOIN; PLECONARIL; PREDNISONE; PROPOFOL; RITUXIMAB; VALPROIC ACID;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ACUTE KIDNEY FAILURE; ANEMIA; ANTIVIRAL THERAPY; ARBOVIRUS; ARTIFICIAL VENTILATION; ASEPTIC MENINGITIS; ASPIRATION; AUTOIMMUNE DISEASE; BRAIN EDEMA; BRAIN INJURY; CALIFORNIA ENCEPHALITIS; CEREBROSPINAL FLUID CULTURE; COMA; COMPUTER ASSISTED TOMOGRAPHY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS ENCEPHALITIS; DEEP SEDATION; DIAGNOSTIC TEST; DRUG MEGADOSE; DRUG PULSE THERAPY; EDEMA; ELECTROENCEPHALOGRAM; ENTEROVIRUS INFECTION; EPILEPTIC STATE; EPSTEIN BARR VIRUS; GLASGOW OUTCOME SCALE; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS 1; HERPES VIRUS; HERPES ZOSTER ENCEPHALITIS; HUMAN; HUMAN HERPESVIRUS 6; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERGLYCEMIA; HYPERTHERMIA; HYPOGLYCEMIA; HYPOTENSION; HYPOXEMIA; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFLUENZA; INTENSIVE CARE UNIT; INTRACRANIAL HYPERTENSION; JC VIRUS; LACTIC ACIDOSIS; LISTERIOSIS; LUMBAR PUNCTURE; MEASLES; MUMPS; MYCOPLASMOSIS; NEUROTOXICITY; PARANEOPLASTIC SYNDROME; PATHOGENESIS; PLASMAPHERESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROPOFOL INFUSION SYNDROME; Q FEVER; RABIES; RESPIRATORY VIRUS; REVIEW; RHABDOMYOLYSIS; SEIZURE; STUPOR; TREATMENT DURATION; TUBERCULOSIS; VASOGENIC EDEMA; VIRUS ENCEPHALITIS; VIRUS REPLICATION; WEAKNESS;

ACUTE DISSEMINATED ENCEPHALOMYELITIS (ADEM); ANTI-NMDA RECEPTOR ANTIBODIES; ARBOVIRUS; COMA; ENCEPHALITIS; HERPES SIMPLEX VIRUS; VARICELLA ZOSTER VIRUS; WEST NILE VIRUS;

ACYCLOVIR; ADRENAL CORTEX HORMONES; ANTICONVULSANTS; ANTIVIRAL AGENTS; BRAIN DISEASES; BRAIN EDEMA; CONSCIOUSNESS DISORDERS; ENCEPHALITIS, VIRAL; ENCEPHALOMYELITIS, ACUTE DISSEMINATED; GLASGOW COMA SCALE; GUILLAIN-BARRE SYNDROME; HASHIMOTO DISEASE; HUMANS; INTENSIVE CARE UNITS; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; SEIZURES; STATUS EPILEPTICUS; VIREMIA;

EID: 84880033863     PISSN: 07490704     EISSN: 15578232     Source Type: Journal    
DOI: 10.1016/j.ccc.2013.03.011     Document Type: Review

References (188)

1. Solomon T., Michael B.D., Smith P.E., et al. Management of suspected viral encephalitis in adults - Association of British Neurologists and British infection Association national guidelines. JInfect 2012, 64:347-373.
2. Steiner I., Budka H., Chaudhuri A., et al. Viral meningoencephalitis: a review of diagnostic methods and guidelines for management. Eur J Neurol 2010, 17:999-1009.
3. Granerod J., Cunningham R., Zuckerman M., et al. Causality in acute encephalitis: defining aetiologies. Epidemiol Infect 2010, 138:783-800.
4. Granerod J., Crowcroft N.S. The epidemiology of acute encephalitis. Neuropsychol Rehabil 2007, 17:406-428.
5. Jmor F., Emsley H.C., Fischer M., et al. The incidence of acute encephalitis syndrome in Western industrialized and tropical countries. Virol J 2008, 5:134.
6. Kulkarni M.A., Lecocq A.C., Artsob H., et al. Epidemiology and aetiology of encephalitis in Canada, 1994-2008: a case for undiagnosed arboviral agents?. Epidemiol Infect 2012, 13:1-13.
7. Huppatz C., Durrheim D.N., Levi C., et al. Etiology of encephalitis in Australia, 1990-2007. Emerg Infect Dis 2009, 15:1359-1365.
8. Granerod J., Tam C.C., Crowcroft N.S., et al. Challenge of the unknown: a systematic review of acute encephalitis in non-outbreak situations. Neurology 2010, 75:924-932.
9. Quist-Paulsen E., Kran A.M., Dunlop O., et al. Infectious encephalitis: a description of a Norwegian cohort. Scand J Infect Dis 2013, 45(3):179-185.
10. Gable M.S., Sheriff H., Dalmau J., et al. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis 2012, 54:899-904.
11. Child N., Croxson M.C., Rahnama F., et al. Aretrospective review of acute encephalitis in adults in Auckland over a five-year period (2005-2009). JClin Neurosci 2012, 19:1483-1485.
12. De Ory F., Avellon A., Echevarria J.E., et al. Viral infections of the central nervous system in Spain: a prospective study. JMed Virol 2013, 85(3):554-562.
13. Granerod J., Ambrose H., Davies N.W., et al. Cause of encephalitis and differences in their presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 2010, 10:835-844.
14. Mailles A., Stahl J.P., Steering Committee and the Investigators Group Infectious encephalitis in France in 2007: a national prospective study. Clin Infect Dis 2009, 49:1838-1847.
15. Steiner I., Kennedy P.G., Pachner A.R. The neurotropic herpes viruses: herpes simplex and varicella-zoster. Lancet Neurol 2007, 6:1015-1028.
16. Hjalmarsson A., Blomqvist P., Skoldenberg B. Herpes simplex encephalitis in Sweden, 1990-2001: incidence, morbidity and mortality. Clin Infect Dis 2007, 45:875.
17. Koskiniemi M., Piiparinen H., Mannonen L., et al. Herpes encephalitis is a disease of middle aged and elderly people: polymerase chain reaction for detection of herpes simplex virus in the CSF of 516 patients with encephalitis. JNeurol Neurosurg Psychiatry 1996, 60:174-178.
18. De Broucker T., Mailles A., Chabrier S., et al. Acute varicella zoster encephalitis without evidence of primary vasculopathy in a case-series of 20 patients. Clin Microbiol Infect 2012, 18:808-819.
19. Hackanson B., Zeiser R., Bley T.A., et al. Fatal varicella zoster virus encephalitis in two patints following allogeneic hematopoietic stem cell transplantation. Clin Transplant 2005, 19:566-570.
20. Baek W., Lee S., Kim Y., et al. Fatal varicella zoster virus vasculopathy associated associated with adalimumab. Arch Neurol 2012, 69:1193-1196.
21. De La Blanchardiere A., Rozenberg F., Caumes E., et al. Neurological complications of varicella-zoster virus infection in adults with human immunodeficiency virus infection. Scand J Infect Dis 2000, 32:263-269.
22. Arribas J.R., Storch G.A., Clifford D.B., et al. Cytomegalovirus encephalitis. Ann Intern Med 1996, 125:577.
23. Doja A., Bitnun A., Jones E.L., et al. Pediatric Epstein-Barr virus associated encephalitis: 10-year review. JChild Neurol 2006, 21:385-391.
24. Fujimoto H., Asaoka K., Imaizumi T., et al. Epstein-Barr virus infections of the central nervous system. Intern Med 2003, 42:33-40.
25. An S.F., Groves M., Martinian L., et al. Detection of infectious agents in brain of patients with acute hemorrhagic leukoencephalitis. JNeurovirol 2002, 8:439-446.
26. McCullers J.A., Lakeman F.D., Whitley R.J. Human herpesvirus 6 is associated with focal encephalitis. Clin Infect Dis 1995, 21:571.
27. Isaacson E., Glaser C.A., Forghani B., et al. Evidence of human herpesvirus 6 in 4 immunocompetent patients with encephalitis. Clin Infect Dis 2005, 40:890.
28. Fotheringham J., Donati D., Akhyani N., et al. Association of human herpesvirus-6B with mesial temporal lobe epilepsy. PLoS Med 2007, 4:e180.
29. Jaskula E., Dlubek D., Sezimirska M., et al. Reactivations of cytomegalovirus, human herpes virus 6 and Epstein-Barr virus differ with respect to risk factors and clinical outcome after hematopoietic stem cell transplantation. Transplant Proc 2010, 42:3273-3276.
30. Fowlkes A.L., Honarmand S., Glaser C., et al. Enterovirus-associated encephalitis in the California Encephalitis Porject, 1998-2005. Clin Infect Dis 2008, 198:1685-1691.
31. Ooi M.H., Wong S.C., Lewthwaite P., et al. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol 2010, 9:1097-1105.
32. Ho M., Chen E.R., Hsu K.H., et al. An epidemic of enterovirus 71 infection in Taiwan. NEngl J Med 1999, 341:929-935.
33. Gould E.A., Solomon T. Pathogenic flaviviruses. Lancet 2008, 371:500-509.
34. Turtle L., Griffiths M.J., Solomon T. Encephalitis caused by flaviviruses. QJM 2012, 105:219-223.
35. Campbell G.L., Hills S.L., Fischer M., et al. Estimated global incidence of Japanese encephalitis: a systematic review. Bull World Health Organ 2011, 89:766-774.
36. Solomon T., Dung N.M., Kneen R., et al. Japanese encephalitis. JNeurol Neurosurg Psychiatry 2000, 68:405-415.
37. Campbell G.L., Marin A.A., Lanciotti R.S., et al. West Nile virus. Lancet Infect Dis 2002, 2:519-529.
38. Kilpatrick A. Globalization, land use, and the invasion of West Nile virus. Science 2011, 334:323-327.
39. Petersen L.R., Hayes E.B. West Nile virus in the Americas. Med Clin North Am 2008, 92:1307-1322.
40. Center for Disease Control and Prevention (CDC) West Nile virus disease and other arboviral diseases - United States, 2011. MMWR Morb Mortal Wkly Rep 2012, 61:510-514.
41. Pealer L.N., Marfin A.A., Petersen L.R., et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. NEngl J Med 2003, 349:1236-1245.
42. Iwamoto M., Jernigan D.B., Guasch A., et al. Transmission of West Nile virus from an organ donor to four transplant recipients. NEngl J Med 2003, 348:2196-2203.
43. Lindquist L., Vapahahti O. Tick-borne encephalitis. Lancet 2008, 371:1861-1871.
44. Raval M., Singhal M., Guerrero D., et al. Powassan virus infection: case series and literature review from a single institution. BMC Res Notes 2012, 5:594.
45. Tavakioli N.P., Wang H., Dupuis M., et al. Fatal case of deer tick virus encephalitis. NEngl J Med 2009, 360:2099-2107.
46. Knox J., Cowan R.U., Doyle J.S., et al. Murray Valley encephalitis: a review of clinical features, diagnosis and treatment. Med J Aust 2012, 196:1-5.
47. Reisen W.K., Lothrop H.D., Wheeler S.S., et al. Persistent West Nile virus transmission and the apparent displacement of St. Louis encephalitis virus in southeastern California, 2003-2006. JMed Entomol 2008, 45(3):494-508.
48. Haddow A.D., Odoi A. The incidence risk, clustering, and clinical presentation of La Crosse virus infections in the Eastern United States, 2003-2007. PLoS One 2009, 4:e6145.
49. Steininger C., Popow-Kraupp T., Laferl H., et al. Acute encephalopathy associated with influenza A virus infection. Clin Infect Dis 2003, 36:567-574.
50. Wang G.F., Li W., Li K. Acute encephalopathy and encephalitis caused by influenza virus infection. Curr Opin Neurol 2010, 23:305-311.
51. Fujimoto S., Kobayashi M., Uemura O., et al. PCR on cerebrospinal fluid to show influenza associated acute encephalopathy or encephalitis. Lancet 1998, 352:873-875.
52. Ekstrand J.J., Herbener A., Rawlings J., et al. Heightened neurologic complications in children with pandemic H1N1 influenza. Ann Neurol 2010, 68:762-766.
53. Calitri C., Gabiano C., Garazzino S., et al. Clinical features of hospitalized children with 2009 H1N1 influenza virus infection. Eur J Pediatr 2010, 169:1511-1515.
54. Surana P., Tang S., McDougall M., et al. Neurological complications of pandemic influenza A H1N1 2009 infection: European case series and review. Eur J Pediatr 2011, 170:1007-1015.
55. Glaser C.A., Winter K., DuBray K., et al. Apopulation-based study of neurologic manifestations of sevre influenza A (H1N1) pdm09 in California. Clin Infect Dis 2012, 55:514-520.
56. Landau Y.E., Grisaru-Soen G., Reif S., et al. Pediatric neurologic complications associated with Influenza A H1N1. Pediatr Neurol 2011, 44:47-51.
57. Carne C.A., Tedder R.S., Smith A., et al. Acute encephalopathy coincident with seroconversion for anti-HTLV-III. Lancet 1985, 2:1206.
58. Tunkel A.R., Glaser C.A., Block K.C., et al. The management of encephalitis: clinical practice guidelines by the Infectious Disease Society of America. Clin Infect Dis 2008, 47:303-327.
59. Sonneville R., Klein I., de Broucker T., et al. Post-infectious encephalitis in adults: diagnosis and management. JInfect 2009, 58:321-328.
60. Sonneville R., Demeret S., Klein I., et al. Acute disseminated encephalomyelitis in the intensive care unit: clinical features and outcome of 20 adults. Intensive Care Med 2008, 34:528-532.
61. De Seze J., Debouverie M., Zephir H., et al. Acute fulminant demyelinating disease: a descriptive study of 60 patients. Arch Neurol 2007, 64:1426-1432.
62. Odada M., Yuki N., Yamada M., et al. Bickerstaff's brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain-Barre syndrome. Brain 2003, 126:2279-2290.
63. Titulaer M.J., McCracken L., Gabilondo I., et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013, 12(2):157-165.
64. Lai M., Huijbers M.G., Lancasater E., et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 2010, 9:776-785.
65. Rosenfeld M., Dalmau J. Paraneoplastic disorders of the CNS and autoimmune synaptic encephalitis. Continuum 2012, 18:366-383.
66. Kramer A.H., Bleck T.P. Neurocritical care of patients with central nervous system infections. Curr Infect Dis Rep 2007, 9:308-314.
67. Young G.B. Coma. Ann N Y Acad Sci 2009, 1157:32-47.
68. Barnett G.H., Ropper A.H., Romeo J. Intracranial pressure and outcome in adult encephalitis. JNeurosurg 1988, 68:585-588.
69. Michael B.D., Solomon T. Seizures and encephalitis: clinical features, management, and potential pathophysiologic mechanisms. Epilepsia 2012, 53(Suppl 4):63-71.
70. Glaser C.A., Gilliam S., Honarmand S., et al. Refractory status epilepticus in suspected encephalitis. Neurocrit Care 2008, 9:74-82.
71. Holtkamp M., Othman J., Buchheim K., et al. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. JNeurol Neurosurg Psychiatry 2005, 76:534-539.
72. Kramer A.H., Jette N., Pillay N., et al. Epileptiform activity in neurocritical care patients. Can J Neurol Sci 2012, 39:328-337.
73. Carrera E., Claassen J., Oddo M., et al. Continuous electroencephalographic monitoring in critically ill patients with central nervous system infections. Arch Neurol 2008, 65:1612-1618.
74. Foreman B., Claassen J., Abou Khaled K., et al. Generalized periodic discharges in the critically ill: a case-control study of 200 patients. Neurology 2012, 79:1951-1960.
75. Sejvar J.J., Bode A.V., Marfin A.A., et al. West Nile virus-associated flaccid paralysis. Emerg Infect Dis 2005, 11:1021-1027.
76. Jeha L.E., Sila C.A., Lederman R.J., et al. West Nile virus infection: a new acute paralytic illness. Neurology 2003, 61:55-59.
77. Baringer J.R. Herpes simplex infections of the nervous system. Neurol Clin 2008, 26:657-674.
78. Conrady C.D., Drevets D.A., Carr D.J. Herpes simplex type I (HSV-1) infection of the nervous system: is an immune response a good thing?. JNeuroimmunol 2010, 220:1-9.
79. Glaser C.A., Honarmand S., Anderson L.J., et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis 2006, 43:1565-1577.
80. Kennedy P.G. Aretrospective analysis of forty-six cases of herpes simplex encephalitis seen in Glasgow between 1962 and 1985. QJM 1988, 68:533-540.
81. Raschilas F., Wolff M., Delatour F., et al. Outcome of and prognostic factors for herpes simplex encephalitis in adult patients: results of a multicenter study. Clin Infect Dis 2002, 35:254-260.
82. Whitley R.J., Soong S.J., Linneman C., et al. Herpes simplex encephalitis. Clinical assessment. JAMA 1982, 247:317-320.
83. Misra U.K., Tan C.T., Kalita J. Viral encephalitis and epilepsy. Epilepsia 2008, 49(Suppl 6):13-18.
84. Sellner J., Trinka E. Seizures and epilepsy in herpes simplex virus encephalitis: current concepts and future directions of pathogenesis and management. JNeurol 2012, 259:2019-2030.
85. Sawlani V. Diffusion-weighted imaging and apparent diffusion coefficient evaluation of herpes simplex encephalitis and Japanese encephalitis. JNeurol 2009, 287:221-226.
86. Duckworth J.L., Hawley J.S., Riedy G., et al. Magnetic resonance restricted diffusion resolution correlates with clinical improvement and response to treatment in herpes simplex encephalitis. Neurocrit Care 2005, 3:251-253.
87. Wasay M., Mekan S.F., Khelaeni B., et al. Extra temporal involvement in herpes simplex encephalitis. Eur J Neurol 2005, 12:475-479.
88. Jubelt B., Mihai C., Li T.M., et al. Rhombencephalitis/brainstem encephalitis. Curr Neurol Neurosci Rep 2011, 11:543-552.
89. Kaji M., Kusuhara T., Ayabe M., et al. Survey of herpes simplex virus infections of the central nervous system, including acute disseminated encephalomyelitis, in the Kyushu and Okinawa regions of Japan. Mult Scler 1996, 2:83-87.
90. Tan I.L., McArthur J.C., Venkatesan A., et al. Atypical manifestations and poor outcome of herpes simplex encephalitis in the immunocompromised. Neurology 2012, 79:2125-2132.
91. Graber J.J., Rosenblum M.K., DeAngelis L.M. Herpes simplex encephalitis in patients with cancer. JNeurooncol 2011, 105:415-421.
92. Gilden D.H., Vafai A., Shtram Y., et al. Varicella-zoster virus DNA in human sensory ganglia. Nature 1983, 306:478-480.
93. Mahalingam R., Wellish M., Wolf W., et al. Latent varicella-zoster viral DNA in human trigemimnal and thoracic ganglia. NEngl J Med 1990, 323:627-631.
94. Koskiniemi M., Rantalaiho T., Piiparinen H., et al. Infections of the central nervous system of suspected viral origin: a collaborative study from Finland. JNeurovirol 2001, 7:400-408.
95. Persson A., Bergstrom T., Lindh M., et al. Varicella-zoster virus CNS disease - viral load, clinical manifestations and sequels. JClin Virol 2009, 46:249-253.
96. Haanpaa M., Dastidar P., Weinberg A., et al. CSF and MRI findings in patients with acute herpes zoster. Neurology 1998, 51:1405-1411.
97. Kleinschmidt-DeMasters B.K., Zmlie-Lefond C., Gilden D.H. The patterns of varicella zoster virus encephalitis. Hum Pathol 1996, 27:927-938.
98. Nagel M.A., Traktinskiy I., Azarkh Y., et al. Varicella zoster virus vasculopathy: analysis of virus-infected arteries. Neurology 2011, 77:364-370.
99. Nagel M.A., Traktinskiy I., Stenmark K.R., et al. Varicella-zoster virus vasculopathy: immune characteristics of virus-infected arteries. Neurology 2013, 80:62-68.
100. Gilden D., Cohrs R.J., Mahalingam R., et al. Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol 2009, 8:731-740.
101. Askalan R., Laughlin S., Mayank S., et al. Chickenpox and stroke in childhood: a study of frequency and causation. Stroke 2011, 32:1257-1262.
102. Braun K.P., Bulder M.M., Chabrier S., et al. The course and outcome of unilateral intracranial arteriopathy in 79 children with ischaemic stroke. Brain 2009, 132:544-557.
103. Nagel M.A., Cohrs R.J., Mahalignam R., et al. The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features. Neurology 2008, 70:853-860.
104. Jemsek J., Greenberg S.B., Tabler L., et al. Herpes zoster-assocaited encephalitis: clinicopathologic report of 12 cases and review of the literature. Medicine 1983, 62:81-97.
105. Kim K.W., Ahn S.W., Park K.Y., et al. Enteroviral encephalitis presenting as rapidly progressive aphasia. JNeurol Sci 2012, 319:156-157.
106. Endres A.S., Helms T., Steinfuhrer S., et al. Transient broca aphasia in an elderly man caused by coxackievirus B5. JNeurol 2002, 249:1318-1319.
107. Cree B.C., Bernardini G.L., Hays A.P., et al. Afatal case of coxackievirus B4 meningoencephalitis. Arch Neurol 2003, 60:107-112.
108. Jang S., Suh S.I., Ha S.M., et al. Enterovirus 71-related encephalomyelitis: usual and unusual magnetic resonance imaging findings. Neuroradiology 2012, 54:239-245.
109. Zeng H., Wen F., Gan Y., et al. MRI and associated clinical characteristics of EV71-induced brainstem encephalitis in children with hand-foot-mouth disease. Neuroradiology 2012, 54:623-630.
110. Sejvar J.J., Haddad M.B., Tierney B.C., et al. Neurologic manifestations and outcome of West Nile virus infection. JAMA 2003, 290:511-515.
111. Pepperell C., Rau N., Krajden S., et al. West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario. CMAJ 2003, 168:1399-1405.
112. Nash D., Mostashari F., Fine A., et al. The outbreak of West Nile virus infection in the New York City area in 1999. NEngl J Med 2001, 344:1807-1814.
113. Weiss D., Carr D., Kellachan J., et al. Clinical findings of West Nile virus infection in hospitalized patients, New York and New Jersey, 2000. Emerg Infect Dis 2001, 7:654-658.
114. Burton J.M., Kern R.Z., Halliday W., et al. Neurological manifestations of West Nile virus infection. Can J Neurol Sci 2004, 31:185-193.
115. Brilla R., Block M., Geremia G., et al. Clinical and neuroradiologic features of 39 consecutive cases of West Nile virus meningoencephalitis. JNeurol Sci 2004, 220:37-40.
116. Tsai T.F., Popovici F., Cernescu C., et al. West Nile encephalitis epidemic in southeastern Romania. Lancet 1998, 352:767-771.
117. Handique S.K. Viral infections of the central nervous system. Neuroimaging Clin N Am 2011, 21:777-794.
118. Zak I.T., Altinok D., Merline J.R., et al. West nile infection. AJR Am J Roentgenol 2005, 184:957-961.
119. Lim C.C. Neuroimaging in postinfectious demyelination and nutritional disorders of the central nervous system. Neuroimaging Clin N Am 2011, 21:843-858.
120. Fugate J.E., Lam E.M., Rabinstein A.A., et al. Acute hemorrhagic leukoencephalitis and hypoxic brain injury associated with H1N1 influenza. Arch Neurol 2010, 67:756-758.
121. Akins P.T., Belko J., Uyeki T.M., et al. H1N1 encephalitis with malignant edema and review of neurologic complications from influenza. Neurocrit Care 2010, 13:396-406.
122. Sonneville R., Klein I.F., Wolff M. Update on investigation and management of postinfectious encephalitis. Curr Opin Neurol 2010, 23:300-304.
123. Lakeman F.D., Whitley R.J. Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. JInfect Dis 1995, 171:857.
124. Ambrose H.E., Granerod J., Clewley J.P., et al. Diagnostic strategy used to establish etiologies of encephalitis in a prospective cohort of patients in England. JClin Microbiol 2011, 49:3576-3583.
125. Gregoire S.M., van Pesch V., Goffette S., et al. Polymerase chain reaction analysis and oligoclonal antibody in the cerebrospinal fluid from 34 patients with varicella-zoster virus infection of the nervous system. JNeurol Neurosurg Psychiatry 2006, 77:938-942.
126. Kupila L., Vuorinen T., Vainionpaa R., et al. Etiology of aseptic meningitis and encephalitis in an adult population. Neurology 2006, 66:75-80.
127. Denne C., Kleines M., Dieckhofer A., et al. Intrathecal synthesis of anti-viral antibodies in pediatric patients. Eur J Paediatr Neurol 2007, 11:29-34.
128. Polage C.R., Petti C.A. Assessment of the utility of viral culture of cerebrospinal fluid. Clin Infect Dis 2006, 43:1578-1579.
129. Skoldenberg B., Forsgren M., Alestig K., et al. Acyclovir versus vidarabine in herpes simplex encephalitis. Randomized multicentre study in consecutive Swedish patients. Lancet 1984, 2:707-711.
130. Whitley R.J., Alford C.A., Hirsch M.S., et al. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. NEngl J Med 1986, 314:144-149.
131. Poissy J., Wolff M., Dewidle A., et al. Factors associated with delay to acyclovir administration in 184 patients with herpes simplex virus encephalitis. Clin Microbiol Infect 2009, 15:560-564.
132. Van Landingham K., Marsteller B., Ross G.W., et al. Relapse of herpes simplex encephalitis after conventional acyclovir therapy. JAMA 1988, 259:1051-1053.
133. Skoldenberg B., Aurelius E., Hjalmarsson A., et al. Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults. JNeurol 2006, 253:163-170.
134. Stahl J.P., Mailles A., De Broucker T., et al. Herpes simplex encephalitis and management of acyclovir in encephalitis patients in France. Epidemiol Infect 2012, 140:372-381.
135. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Long term treatment of herpes simplex encephalitis (HSE) with Valtrex. Available at: Accessed January 1, 2013. http://clinicaltrials.gov/ct2/show/NCT00031486.
136. Sawyer M.H., Webb D.E., Balow J.E., et al. Acyclovir-induced renal failure. Clinical course and histology. Am J Med 1988, 84:1067-1071.
137. Blohm M.E., Nurnberger W., Aulich A., et al. Reversible brain MRI changes in acyclovir neurotoxicity. Bone Marrow Transplant 1997, 19:1049-1051.
138. Ernst M.E., Franey R.J. Acyclovir- and ganciclovir-induced neurotoxicity. Ann Pharmacother 1998, 32:111-113.
139. Davies N., Brown L.J., Gonde J., et al. Factors influencing PCR detection of viruses in cerebrospinal fluid of patients with suspected CNS infections. JNeurol Neurosurg Psychiatry 2005, 76:82-87.
140. Wallace M.R., Bowler W.A., Murray N.B., et al. Treatment of adult varicella with oral acyclovir. A randomized, placebo-controlled trial. Ann Intern Med 1992, 117:358-363.
141. Wood M.J., Kay R., Dworkin R.H., et al. Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials. Clin Infect Dis 1996, 22:341-347.
142. Desmond R.A., Accortt N.A., Talley L., et al. Enteroviral meningitis: natural history and outcome of pleconaril therapy. Antimicrob Agents Chemother 2006, 50:2409-2414.
143. Treanor J.J., Hayden F.G., Vrooman P.S., et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. JAMA 2000, 283:1016-1024.
144. Upton A.R., Barwick D.D., Foster J.B. Dexamethasone treatment in herpes-simplex encephalitis. Lancet 1971, 1:290-291.
145. Habel A.H., Brown J.K. Dexamethasone in herpes-simplex encephalitis. Lancet 1972, 1:695.
146. Meyding-Lamade U.K., Oberlinner C., Rau P.R., et al. Experimental herpes simplex virus encephalitis: a combination therapy of acyclovir and glucocorticoids reduces long-term magnetic resonance imaging abnormalities. JNeurovirol 2003, 9:118-125.
147. Thompson K.A., Blessing W.W., Wesselingh S.L. Herpes simplex replication and dissemination is not increased by corticosteroid treatment in a rat model of focal herpes. JNeurovirol 2000, 6:25-32.
148. Kamei S., Sekizawa T., Shiota H., et al. Evaluation of combination therapy using acyclovir and corticosteroid in adult patients with herpes simplex virus encephalitis. JNeurol Neurosurg Psychiatry 2005, 76:1544-1549.
149. Martinez-Torres F., Menon S., Pritsch M., et al. Protocol for German trial of acyclovir and corticosteroids in herpes-simplex-virus-encephalitis: a multicenter, multi-national, randomized, double-blind, placebo-controlled German, Austrian and Dutch trial. BMC Neurol 2008, 8:40.
150. Wood M.J., Johnson R.W., McKendrick M.W., et al. Arandomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. NEngl J Med 1994, 330:896-900.
151. Whitley R.J., Weiss H., Gnann J.W., et al. Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. Ann Intern Med 1996, 125:376-383.
152. Kramer A.H., Zygun D.A. Do neurocritical care units save lives? Measuring the impact of specialized ICUs. Neurocrit Care 2011, 14:329-333.
153. Kramer A.H., Zygun D.A. Anemia and red blood cell transfusion in neurocritical care. Crit Care 2009, 13:R89.
154. Kramer A.H., Roberts D.J., Zygun D.A. Optimal glycemic control in neurocritical care patients: a systematic review and meta-analysis. Crit Care 2012, 16:R203.
155. Hutchison J.S., Frndova H., Lo T.Y., et al. Impact of hypotension and low cerebral perfusion pressure on outcomes in children treated with hypothermia therapy following severe traumatic brain injury: a post hoc analysis of the Hypothermia Pediatric Head Injury Trial. Dev Neurosci 2010, 32:406-412.
156. Diringer M.N., Reaven N.L., Funk S.E., et al. Elevated body temperature independently contributes to increased length of stay in neurologic intensive care unit patients. Crit Care Med 2004, 32:1489-1495.
157. Young G.B., Jordan K.G., Doig G.S. An assessment of nonconvulsive seizures in the intensive care unit using continuous EEG monitoring: an investigation of variables associated with mortality. Neurology 1996, 47:83-89.
158. Rebaud P., Berthier J.C., Hartemann E., et al. Intracranial pressure in childhood central nervous system infections. Intensive Care Med 1988, 14:522-525.
159. Solomon T., Dung N.M., Kneen R., et al. Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis. Brain 2002, 125:1084-1093.
160. Woodcock J., Ropper A.H., Kennedy S.K. High dose barbiturates in non-traumatic brain swelling: ICP reduction and effect on outcome. Stroke 1982, 13:785-787.
161. Schwab S., Junger E., Spranger M., et al. Craniectomy: an aggressive treatment approach in severe encephalitis. Neurology 1997, 48:412-417.
162. Taferner E., Prausler B., Kofler A., et al. Craniectomy in severe, life-threatening encephalitis: a report on outcome and long-term prognosis of four cases. Intensive Care Med 2001, 27:1426-1428.
163. Yan H.J. Herpes simplex encephalitis: the role of surgical decompression. Surg Neurol 2002, 57:20-24.
164. Sanchez-Carpintero R., Aguilera S., Idoate M., et al. Temporal lobectomy in acute complicated herpes simplex encephalitis: technical case report. Neurosurgery 2008, 62:E1174-E1175.
165. Gonzalez-Rabelino G.A., Fons C., Rey A., et al. Craniectomy in herpetic encephalitis. Pediatr Neurol 2008, 39:201-203.
166. Citerio G., Sala F., Patruno A., et al. Influenza A (H1N1) encephalitis with severe intracranial hypertension. Minerva Anestesiol 2010, 76:459-462.
167. Wagner I., Staykov D., Volbers B., et al. Therapeutic hypothermia for space-occupying herpes simplex virus encephalitis. Minerva Anestesiol 2011, 77:371-374.
168. Hayton E., Wakerley B., Bowler I.C., et al. Successful outcome of Epstein-Barr virus encephalitis managed with bilateral craniectomy, corticosteroids and acyclovir. Pract Neurol 2012, 12:234-237.
169. Chesnut R.M., Temkin N., Carney N., et al. Atrial of intracranial-pressure monitoring in traumatic brain injury. NEngl J Med 2012, 367:2471-2481.
170. Cooper D.J., Rosenfeld J.V., Murray L., et al. Decompressive craniectomy in diffuse traumatic brain injury. NEngl J Med 2011, 361:1493-1502.
171. Brophy G.M., Bell R., Claassen J., et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 2012, 17:3-23.
172. Rossetti A.O., Lowenstein D.H. Management of refractory status epilepticus in adults: still more questions than answers. Lancet Neurol 2011, 10:922-930.
173. Shneker B.F., Fountain N.B. Assessment of acute morbidity and mortality in nonconvulsive status epilepticus. Neurology 2003, 61:1066-1073.
174. Stewart C.P., Otsubo H., Ochi A., et al. Seizure identification in the ICU using quantitative EEG displays. Neurology 2010, 75:1501-1508.
175. Iyer V.N., Hoel R., Rabinstein A.A. Propofol infusion syndrome in patients with refractory status epilepticus: an 11-year clinical experience. Crit Care Med 2009, 37:3024-3030.
176. Kramer A.H. Early ketamine to treat refractory status epilepticus. Neurocrit Care 2012, 16:299-305.
177. Holtkamp M., Othman J., Buchheim K., et al. A"malignant" variant of status epilepticus. Arch Neurol 2005, 62:1428-1431.
178. Legriel S., Mourvillier B., Bele N., et al. Outcomes in 140 critically ill patients with status epilepticus. Intensive Care Med 2008, 34:476-480.
179. Cooper A.D., Britton J.W., Rabinstein A.A. Functional and cognitive outcome in prolonged refractory status epilepticus. Arch Neurol 2009, 66:1505-1509.
180. Tenembaum S., Chamoles N., Fejerman N. Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients. Neurology 2000, 59:1224-1231.
181. Sahlas D.J., Miller S.P., Guerin M., et al. Treatment of acute disseminated encephalomyelitis with intravenous immunoglobulin. Neurology 2000, 54:1370.
182. Khurana D.S., Melvin J.J., Kothare S.V., et al. Acute disseminated encephalomyelitis in children: discordant neurologic and neuroimaging abnormalities and response to plasmapheresis. Pediatrics 2005, 116:431.
183. Smith J.H., Dhamija R., Mosely B.D., et al. N-metyl-D-aspartate receptor autoimmune encephalitis presenting with opsoclonus-myoclonus: treatment response to plasmapheresis. Arch Neurol 2011, 68:1069.
184. Ishiura H., Matsuda S., Higashihara M., et al. Response of anti-NMDA receptor encephalitis without tumor to immunotherapy including rituximab. Neurology 2008, 71:1921.
185. Kashyape P., Taylor E., Ng J., et al. Successful treatment of two pediatric cases of anti-NMDA receptor encephalitis with cyclophosphamide: the need for early aggressive immunotherapy in tumour negative pediatric patients. Eur J Paediatr Neurol 2012, 16:74-78.
186. McGrath N., Anderson N.E., Croxson M.C., et al. Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome. JNeurol Neurosurg Psychiatry 1997, 63:321-326.
187. Gordon B., Selnes O.A., Hart J., et al. Long-term cognitive sequelae of acyclovir-treated herpes simplex encephalitis. Arch Neurol 1990, 47:646-647.
188. Hynson J.L., Kornberg A.J., Coleman L.T., et al. Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children. Neurology 2001, 56:1308-1312.